TP53 and malignant colon neoplasm: Further support for the view that GSK-3β controls let-7 levels in a p53-dependent manner came from analysis of the colon cancer cell line HCT116, where wild-type cells (wt, expressing p53) and p53-null cells (obtained by somatic deletion of both p53 alleles [46]) were analyzed.